rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
1997-1-14
|
pubmed:abstractText |
Tricyclic antidepressants (TCAs) play an important role in the treatment of pediatric psychiatric disorders. Despite widespread clinical use, concerns about their possible cardiovascular risk have arisen following several published reports of sudden death associated with their use in children. Accordingly, available evidence concerning TCA-associated cardiovascular effects in children and adolescents was surveyed.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0890-8567
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1491-501
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8936916-Adolescent,
pubmed-meshheading:8936916-Adult,
pubmed-meshheading:8936916-Antidepressive Agents, Tricyclic,
pubmed-meshheading:8936916-Blood Pressure,
pubmed-meshheading:8936916-Child,
pubmed-meshheading:8936916-Child, Preschool,
pubmed-meshheading:8936916-Death, Sudden, Cardiac,
pubmed-meshheading:8936916-Electrocardiography, Ambulatory,
pubmed-meshheading:8936916-Exercise Test,
pubmed-meshheading:8936916-Female,
pubmed-meshheading:8936916-Heart Rate,
pubmed-meshheading:8936916-Humans,
pubmed-meshheading:8936916-Male,
pubmed-meshheading:8936916-Risk Factors
|
pubmed:year |
1996
|
pubmed:articleTitle |
Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.
|
pubmed:affiliation |
Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review,
Research Support, Non-U.S. Gov't
|